Funding
Macquarie Uni biotech spin out raises $16.8m Series A
A biotech startup hoping to use gene therapy to treat neurodegenerative diseases such as Motor Neurone Disease (MND), epilepsy and dementia has raised $16.75 million in a Series A. The round for Celosia Therapeutics was led by research commercialisation fund Uniseed, with support from UniSuper and hedge fund manager Iomar Barrett, who has amyotrophic lateral… Read more »
